Navigation Links
ITRA Global Report Makes the Case That Bio Tech Companies Should Consider Tucson, Arizona for Relocation or Expansion
Date:11/27/2013

Tucson, Arizona (PRWEB) November 27, 2013

Tucson, Arizona should be on any bioscience or biotechnology company’s short list for relocation or expansion, according to a white paper issued by ITRA Global affiliate Commercial Real Estate Group of Tucson LLC.

The nine-page report, “The Bio Industry in Tucson, Arizona,” points out that several bioscience companies already thrive in the region, including Ventana Medical Systems, Sanofi and SynCardia Systems. It also mentions that Accelerate Diagnostics moved from Denver to Tucson in 2012.

“I was impressed from my first contacts with Pima County, the Tucson mayor’s office, the state of Arizona and the Tucson Regional Economic Opportunities Office,” Accelerate President and CEO, Lawrence Mehren, is quoted as saying in the white paper. “We could tell this was a place that valued our businesses and wanted to help.”

“Proximity to large private enterprises in bioscience is only one of the reasons Tucson is a rising biotechnology star,” says Michael Coretz, principal of Commercial Real Estate Group of Tucson / ITRA Global. “Our city also boasts available venture capital, an encouraging spirit of entrepreneurship and a strong research community, including the University of Arizona’s Bio5 Institute.”

The availability of federal and state government funding and a highly skilled workforce are other reasons Tucson, the hub of Southern Arizona, should get prime consideration by biotechnology and bioscience firms, the report says.

Commercial Real Estate of Tucson is the Tucson Affiliate of ITRA Global and Michael Coretz is a site selection expert with indepth knowledge of biotech companies for local, regional and national clients. Specialized real estate needs for this industry are addressed in the white paper, which is available on the CREG of Tucson website.

ITRA Global is an organization of commercial real estate firms specializing in the representation of tenants and buyers of office, industrial, and retail facilities. It is one of the largest commercial real estate organizations devoted to representing corporate tenants and buyers. With coverage in major markets around the world, ITRA Global consists of seasoned professionals with an average of twenty years’ experience and is differentiated by its focus on advocacy for the corporate tenant and buyer. Clients benefit by having an experienced professional as their trusted advisor -- conflict-free representation with total objectivity.

For more information about the white paper, contact Michael Coretz by telephone at +1.520.299.3400 or by email, michael(at)cretucson.com. For more information about ITRA Global, you may contact the Executive Director of the organization, Beth Wade at +1.706.654.3201.

Read the full story at http://www.prweb.com/releases/2013/11/prweb11374985.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
2. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
3. Global Cleantech Cluster Association Names New York City Startup Rentricity to Global Top 10 List
4. StemCyte Adds World Class Talent to its North America and Global Operations
5. Sequenom Named to NASDAQ Global Select Market
6. Synthetic Biology: Emerging Global Markets
7. MacroGenics Receives Milestone Payment as Part of Its Global DART™ Alliance with Boehringer Ingelheim
8. Amgen to Present at the 30th Annual J.P. Morgan Global Healthcare Conference
9. Hemodialysis Machine Industry 2012 Global & China Market Research Report - ReportsnReports
10. MarketsandMarkets: Global Seed Treatment Market worth $3430.3 Million by 2016
11. Accuray Surpasses 600 Installations Globally
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ROTTERDAM, the Netherlands and LAGUNA HILLS, ... that The Institute of Cancer Research, London ... will use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify ... high-risk trial known as MUK nine . The University ... this trial, which is partly funded by Myeloma UK, and ...
(Date:10/10/2017)... , ... October 10, 2017 ... ... cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing ... HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... optimization firm for the life sciences and healthcare industries, announces a presentation by ... Francisco. , The presentation, “Automating GxP Validation for Agile Cloud Platforms,” will present ...
(Date:10/9/2017)... ... October 09, 2017 , ... The ... medical marijuana products targeting the needs of consumers who are incorporating medical marijuana ... place in Phoenix, Arizona. , As operators of two successful Valley dispensaries, The ...
Breaking Biology Technology:
(Date:3/24/2017)... The Controller General of Immigration from Maldives Mr. Mohamed ... received the prestigious international IAIR Award for the most innovative high security ... ... Maldives Immigration Controller General, ... picture on the right) have received the IAIR award for the "Most ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based ... to 2022", published by MarketsandMarkets, the market is expected to be worth USD ... 2022. Continue Reading ... ... ...
(Date:3/22/2017)... VILNIUS, Lithuania , March 21, 2017 /PRNewswire/ ... identification and object recognition technologies, today announced the ... development kit (SDK), which provides improved facial recognition ... safety cameras on a single computer. The new ... algorithms to improve accuracy, and it utilizes a ...
Breaking Biology News(10 mins):